Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders
Alzheimer's Disease
- Publisher's listprice EUR 163.99
-
68 014 Ft (64 776 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 6 801 Ft off)
- Discounted price 61 213 Ft (58 298 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
68 014 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 2
- Publisher Elsevier Science
- Date of Publication 1 November 2025
- ISBN 9780443300080
- Binding Hardback
- No. of pages400 pages
- Size 234x190 mm
- Weight 450 g
- Language English 700
Categories
Long description:
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease, Second Edition delves into the complexities of drug discovery, specifically for Alzheimer's Disease, presenting the necessary paradigm for future success in research and treatment. This edition is thoroughly updated with recent developments in therapeutic strategies, including amyloid hypothesis, tau, apo E, insulin, and others, and introduces a new chapter on drug delivery to the brain. Additionally, the book encompasses diagnosis, epidemiology, drug discovery strategies, current therapeutics, and more, offering a comprehensive approach to Alzheimer's Disease.
It covers the latest in targeted drug design, preclinical studies, and animal models, making it an essential resource for pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers. Patients and advocacy groups can also gain valuable insights from the overview of current treatments and scientific advancements in the field.
Table of Contents:
1. Neurodegenerative disorders: why do we need new therapies?
2. Cognitive and functional considerations in Alzheimer’s disease diagnosis
3. National plan and resources to address Alzheimer’s disease
4. Biosensor approaches in the diagnosis of a neurodegenerative disorder
5. Current therapies for the treatment of Alzheimer’s disease: small molecules - Acetylcholine esterase inhibitors and NMDA receptor antagonist
6. Physicochemical properties for potential AD drugs
7. Receptor targets in Alzheimer’s disease drug discovery
8. Amyloid hypothesis in the development of therapeutic agents for Alzheimer’s disease 9: Tau proteins
10. Cholesterol and fat metabolism in Alzheimer’s disease
11. Mitochondria as a therapeutic target for the treatment of Alzheimer’s disease
12. Peptide-based therapeutics
13. Anti-inflammatory and immunomodulating agents
14. Prion and other protein folding hypotheses
15. Simple in vivo models of Alzheimer’s disease
16. Rodent models for Alzheimer’s disease drug discovery
17. Drug delivery to the brain
18. Alzheimer’s disease drugs in clinical trials
19. Biologics for the treatment of Alzheimer’s disease
20. Brain health
21. Non-pharmacologic treatment approaches
